Solara Active Pharma Income Statement

Quarterly

Yearly

home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20212022
EBITDA41499
EBIT305-16
Earning Per Share64-16
Expenses1,2311,188
Net Profit221-58
Net Profit Margin14-5
Operating Profit Margin268
Profit Before Tax222-91
Dividends Per Share70
Operation Revenue1,6461,288

Peer Comparison (in ₹.Cr.)

CompanyYearEBITEBITDANet ProfitNet WorthProfit Before Tax
202298.23103.1086.202,445.2397.80
20221,739.202,486.90993.609,042.131,441.20
2022-1,229.80428.90-1,509.7011,900.64-1,372.50
20223,086.904,252.102,112.2018,985.902,991.10
20224,608.6011,319.203,405.8047,771.294,481.30
The EBITDA of Solara Active Pharma is 99 as of 3/28/2023
home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20182019202020212022
Operating Activities49166242155-242
Investing Activities-85-116-359-106-243
Financing Activities68-239792334
Others00000
Net Cash Flow3127-20142-151

Peer Comparison (in ₹.Cr.)

CompanyYearOperating ActivitiesInvesting ActivitiesFinancing ActivitiesNet Cash Flow
2022-17.7518.85-5.82-4.72
20221,108.65-333.28-520.49254.88
2022367.311,292.23-1,572.3287.22
20163,262.60-2,039.40-1,700.10-476.90
20183,907.15-3,370.81-1,539.26-1,002.92
The cash flow from Operating Activities of Solara Active Pharma is -242 as of 3/28/2023